Ran Wang
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 10%
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Research and Splicing
Papers in
-
- Circular RNAs in diseases 13
- RNA modifications and cancer 11
- Advanced biosensing and bioanalysis techniques 8
- Connective Tissue Growth Factor Research 8
- PI3K/AKT/mTOR signaling in cancer 5
-
- Pulmonary Hypertension Research and Treatments 16
- Co-authors
- Sijing Zhou (38 shared papers)Daxiong Zeng (19 shared papers)Yi Liu (13 shared papers)Guanghe Fei (15 shared papers)Xiaohui Sun (2 shared papers)Xiansheng Liu (8 shared papers)Yongjian Xu (7 shared papers)Peipei Wu (7 shared papers)
- Journals
- Journal of Cellular Biochemistry (4 papers)Oncotarget (4 papers)Cellular Physiology and Biochemistry (4 papers)Advanced Functional Materials (4 papers)Cancer Medicine (3 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Ran Wang
164 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 137
- Cancer Research 715
- Molecular Biology 1.2k
- Pulmonary and Respiratory Medicine 438
- Microbiology 10
- Geriatrics and Gerontology 42
Countries citing papers authored by Ran Wang
This map shows the geographic impact of Ran Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ran Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ran Wang more than expected).
Fields of papers citing papers by Ran Wang
This network shows the impact of papers produced by Ran Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ran Wang. The network helps show where Ran Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ran Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 176 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 137 | |
| 2 | Increased expression of lncRNA HULC indicates a poor prognosis and promotes cell metastasis in osteosarcoma. | 2015 | 97 |
| 3 | 2014 | 83 | |
| 4 | 2019 | 64 | |
| 5 | 2021 | 62 | |
| 6 | 2019 | 59 | |
| 7 | 2015 | 57 | |
| 8 | 2018 | 57 | |
| 9 | 2016 | 54 | |
| 10 | 2012 | 53 | |
| 11 | 2020 | 49 | |
| 12 | 2021 | 49 | |
| 13 | 2020 | 48 | |
| 14 | 2014 | 47 | |
| 15 | 2019 | 44 | |
| 16 | 2015 | 42 | |
| 17 | 2016 | 38 | |
| 18 | 2008 | 37 | |
| 19 | 2015 | 35 | |
| 20 | 2021 | 35 |
About Ran Wang
Ran Wang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, Oncology and Physiology, having authored 176 papers that have together received 2.7k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (20 papers), MicroRNA in disease regulation (17 papers), Pulmonary Hypertension Research and Treatments (16 papers), Circular RNAs in diseases (13 papers), RNA modifications and cancer (11 papers), Advanced biosensing and bioanalysis techniques (8 papers), Connective Tissue Growth Factor Research (8 papers) and PI3K/AKT/mTOR signaling in cancer (5 papers). The work is most often cited by research in Cancer Research (715 citations), Molecular Biology (1.2k citations), Pulmonary and Respiratory Medicine (438 citations), Microbiology (10 citations) and Geriatrics and Gerontology (42 citations). Ran Wang has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Sijing Zhou, Daxiong Zeng, Yi Liu, Guanghe Fei, Xiaohui Sun, Xiansheng Liu, Yongjian Xu, Peipei Wu, Min Yang and Qingqing Ouyang. Their work appears in journals such as Journal of Cellular Biochemistry, Oncotarget, Cellular Physiology and Biochemistry, Advanced Functional Materials and Cancer Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.